{"id":40268,"date":"2017-10-02T15:34:00","date_gmt":"2017-10-02T14:34:00","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/bmj\/?p=40268"},"modified":"2017-10-02T15:34:00","modified_gmt":"2017-10-02T14:34:00","slug":"partnership-between-the-bmj-and-pfizer-learn-and-change-to-improve-the-evidence","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/bmj\/2017\/10\/02\/partnership-between-the-bmj-and-pfizer-learn-and-change-to-improve-the-evidence\/","title":{"rendered":"Partnership between the BMJ and Pfizer: Learn and change to improve the evidence"},"content":{"rendered":"<p><span style=\"font-weight: 400\">People do health research for many different reasons. Most, we hope, try to answer questions that are important to patient care or policy, with a chance of informing service development or improving health. This is particularly<\/span> <a href=\"http:\/\/www.who.int\/whr\/2013\/report\/en\/\"><span style=\"font-weight: 400\">urgent in lower income countries<\/span><\/a><span style=\"font-weight: 400\">,<\/span><span style=\"font-weight: 400\"> where there is still not nearly enough locally derived evidence to drive and support healthcare development and improvement.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Yet research too often starts with suboptimal questions or <\/span><a href=\"https:\/\/stg-blogs.bmj.com\/bmj\/2017\/06\/05\/paul-glasziou-and-iain-chalmers-can-it-really-be-true-that-50-of-research-is-unpublished\/\"><span style=\"font-weight: 400\">loses its way<\/span><\/a><span style=\"font-weight: 400\">, l<\/span><span style=\"font-weight: 400\">eading to rejection or retraction from journals and skewing the evidence base for health<\/span><span style=\"font-weight: 400\">. <\/span><a href=\"http:\/\/jme.bmj.com\/content\/37\/9\/567\"><span style=\"font-weight: 400\">One study<\/span><\/a><span style=\"font-weight: 400\">, for instance, showed that, among 312 papers retracted from Medline, 40% were withdrawn owing to errors or non-replicable findings.<\/span><\/p>\n<p><span style=\"font-weight: 400\">How can we meet these challenges, and ensure that the resources for health research <\/span><a href=\"http:\/\/rewardalliance.net\/\"><span style=\"font-weight: 400\">yield the greatest possible value<\/span><\/a><span style=\"font-weight: 400\">? Many health researchers get some advice on how to use statistics and write papers, but relatively few, worldwide, receive enough support from their institutions to develop good research questions, use the best study designs, and properly report studies\u2019 methods and results.<\/span><\/p>\n<p><span style=\"font-weight: 400\">So that\u2019s why BMJ developed the<\/span> <a href=\"http:\/\/rtop.bmj.com\/\"><span style=\"font-weight: 400\">Research to Publication <\/span><\/a><span style=\"font-weight: 400\">elearning <\/span><span style=\"font-weight: 400\">programme, <\/span><span style=\"font-weight: 400\">to help <\/span><span style=\"font-weight: 400\">research institutions in Africa, South Asia, Latin America, Europe, and beyond to <\/span><a href=\"http:\/\/www.bmj.com\/content\/352\/bmj.i796\"><span style=\"font-weight: 400\">build capabilities<\/span><\/a><span style=\"font-weight: 400\"> f<\/span><span style=\"font-weight: 400\">or trustworthy, publishable, and usable health research. <\/span><a href=\"http:\/\/gh.bmj.com\/content\/2\/2\/e000229\"><span style=\"font-weight: 400\">Systematic analysis<\/span><\/a><span style=\"font-weight: 400\"> suggests that capacity development for clinical research depends on five main types of competency and, of these, professional skills and scientific thinking are critically important. Research to Publication offers the tools to develop professional skills and scientific thinking\u2014ultimately contributing to the development of capacity to conduct high quality, relevant clinical research.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The BMJ and Pfizer\u2019s Independent Grants for Learning and Change (IGLC) are pleased to announce the launch of two competitive grant programmes intended to encourage research and healthcare institutions to apply for access to the Research to Publication e-learning modules, the purchase of which will be funded by Pfizer.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The mission of Pfizer\u2019s IGLC Programme is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. In partnering with the BMJ to provide access to Research to Publication, Pfizer is seeking to help improve both the conduct and publication of clinical research in medical, dental, nursing, allied health, and\/or pharmacy professional schools and in other academic institutions and healthcare settings.<\/span><span style=\"font-size: 1rem\">\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The two competitive grant programmes will be a call for applications from institutions in <\/span><span style=\"font-weight: 400\">low and low-to-middle income countries in Europe, Africa, and the Middle East <\/span><span style=\"font-weight: 400\">(apply <\/span><a href=\"http:\/\/www.pfizer.com\/sites\/default\/files\/rfp_files\/IGLC_RFP_2017RES1_ResearchtoPublication_International.pdf\"><span style=\"font-weight: 400\">here<\/span><\/a><span style=\"font-weight: 400\">) and another call for applications from institutions in the UK (apply <\/span><a href=\"http:\/\/www.pfizer.com\/sites\/default\/files\/rfp_files\/IGLC_RFP_2017RES2_ResearchtoPublication_UK.pdf\"><span style=\"font-weight: 400\">here<\/span><\/a><span style=\"font-weight: 400\">).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Applicants will need to show that they have:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">a mission related to healthcare improvement <\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">clearly demonstrable needs for the training offered by Research to Publication (and, in the LMICs track, priority will be given to institutions in the lowest income countries)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">a detailed implementation plan explaining how the training will be utilised and how individuals will be reached and supported to ensure that they can access the programme<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">a sizeable number of current or potential researchers (applications should specify whether access to Research to Publication is needed for up to 50, 100, 150, 200, or 250 learners &#8211; or for more than 250 if the need is demonstrable)<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400\">Grant applications will be considered by one of two independent, expert and multidisciplinary external review panels, one for each call, who will be assessing the submissions and awarding the grants enabling one year\u2019s full access to the Research to Publication. Pfizer will fund institutional subscriptions to Research to Publication on behalf of the successful organisations via an educational grant provided to the BMJ, with access then granted direct by BMJ.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Although Pfizer will ask for reports to be shared publicly about the impact of Research to Publication<\/span><span style=\"font-weight: 400\">, <\/span><span style=\"font-weight: 400\">the company will have no influence over any aspect of any resulting studies. No funds will be transferred to the organisations to whom access to Research to Publication is awarded.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Research to Publication is already being used by universities and medical schools in Africa, South Asia, Latin America, as well as in the UK and Australia. With this BMJ and Pfizer partnership we can reach many more.<\/span><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Trish Groves<\/strong> has been an editor at <\/span><\/em><span style=\"font-weight: 400\">The BMJ<\/span><em><span style=\"font-weight: 400\"> since 1989 and is the editorial lead for Research to Publication.<\/span><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Competing interests<\/strong> for TG: As well as my roles at <\/span><\/em><span style=\"font-weight: 400\">The BMJ<\/span><em><span style=\"font-weight: 400\"> and Research to Publication I am Editor in chief of <\/span><\/em><span style=\"font-weight: 400\">BMJ Open<\/span><em><span style=\"font-weight: 400\"> and Director of academic outreach at BMJ. Both <\/span><\/em><span style=\"font-weight: 400\">The BMJ<\/span><em><span style=\"font-weight: 400\"> and <\/span><\/em><span style=\"font-weight: 400\">BMJ Open<\/span><em><span style=\"font-weight: 400\"> publish research with open access, levying article publishing charges. Part of the revenue for BMJ (the company) comes from drug &amp; device manufacturers through advertising, reprint sales, &amp; sponsorship. My annual bonus scheme is based partly on the overall financial performance of both BMJ and Research to Publication.<\/span><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Berkeley Phillips<\/strong> has an NHS background in cardiology and internal medicine and joined Pfizer\u2019s Medical Department in 2001, becoming Medical Director in 2010.<\/span><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Competing interests<\/strong> for BP: I am an employee of Pfizer.<\/span><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>People do health research for many different reasons. Most, we hope, try to answer questions that are important to patient care or policy, with a chance of informing service development or improving health. This is particularly urgent in lower income countries, where there is still not nearly enough locally derived evidence to drive and support [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/stg-blogs.bmj.com\/bmj\/2017\/10\/02\/partnership-between-the-bmj-and-pfizer-learn-and-change-to-improve-the-evidence\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":40269,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[116],"tags":[],"class_list":["post-40268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-editors-at-large"],"jetpack_featured_media_url":"https:\/\/stg-blogs.bmj.com\/bmj\/files\/2017\/10\/research_to_publication.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/40268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=40268"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/40268\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/40269"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=40268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=40268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=40268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}